Source: Eur Respir J 2004; 23: 620-628



Rating:

Share or cite this content

Citations should be made in the following way:
Buhling F., Waldburg N., Reisenauer A., Heimburg A., Golpon H., Welte T.. Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation. Eur Respir J 2004; 23: 620-628

Member's Comments

No comment yet.

Related content which might interest you: SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition Source: Eur Respir J 2011; 37: 1083-1090 Year: 2011 Cathepsins in bleomycin-induced lung injury in rat Source: Eur Respir J 2003; 22: 427-435 Year: 2003 Dipeptidyl peptidase I (DPPI) cleaves surfactant protein D (SP-D): A mechanism for immune compromise in the lung Source: International Congress 2016 – Molecular immunology of the lung Year: 2016 The proteasome - an intracellular protease that is dysregulated in lung diseases Source: International Congress 2018 – Proteases: at the cutting edge of lung disease Year: 2018 The role of matrix metalloproteinases in cystic fibrosis lung disease Source: Eur Respir J 2011; 38: 721-727 Year: 2011 Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights Source: Eur Respir J 2009; 33: 475-488 Year: 2009 Inhibition of airway proteases in cystic fibrosis lung disease Source: Eur Respir J 2008; 32: 783-795 Year: 2008 Localizing the proteolytic activity: lysosomal and extracellular Cystein cathepsins Source: ERS Research Seminar 2015 Year: 2015 Type II transmembrane serine protease matriptase is a mediator of pulmonary fibrosis Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Loss of structural integrity and function of surfactant protein D (SP-D) by cystic fibrosis- related proteases Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001 The role of cathepsin S in lung disease Source: International Congress 2018 – Proteases: at the cutting edge of lung disease Year: 2018 Decreased levels of secretory leucoprotease inhibitor in the pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Development of secretory leukocyte protease inhibitor (SLPI) variants resistant to degradation by neutrophil elastase Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection Source: Lung Science Conference 2015 Year: 2015 LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Potential role of cathepsin S in bleomycin-induced lung fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 729s Year: 2005 Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vivo Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Emerging roles of human cysteine proteases in fibrosis and infection Source: ERS Research Seminar 2015 Year: 2015 Clinical status and activity of lysosomal carboxypeptidase A and cathepsin D in mixed saliva of cystic fibrosis patients Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008 Decreased levels of elafin in the lungs of patients with acute lung injury as a result of proteolytic cleavage by the proteasome Source: Annual Congress 2012 - Mechanistic studies in airway cell biology Year: 2012